Category: Safety Assessment
EPL Announces New President
EPL is pleased to announce the promotion of Dr. Kathleen Funk to President of EPL on June 1, 2016. Dr. Funk has served as the Chief Operating Officer since 2014. Dr. Funk is a graduate of the Virginia-Maryland Regional College of Veterinary Medicine and also holds a PhD in Comparative Pathology from the University of […]
EPL and Histion Form Strategic Alliance to Enhance Medical Device and Biomaterial Testing
EPL announces a newly formed strategic alliance with Histion, an Everett, Washington based preclinical laboratory specializing in GLP-compliant routine and specialty histology and evaluation services. This alliance is specifically targeted to expand and enhance EPL’s and Histion’s capabilities to an ever expanding area of medical device and novel biomaterial testing. Although Histion specializes in processing […]
EPL, Inc. Opens a Northeast Office in Collegeville, Pennsylvania
Experimental Pathology Laboratories, Inc. (EPL®) established EPL Northeast on February 8, 2016. This office is headed by Dr. Heath Thomas who was formerly Vice President of Safety Assessment at GlaxoSmithKline. The Northeast office is located outside of Philadelphia at 125 Chinaberry Lane, Collegeville, PA. With this location, Dr. Thomas will be able to provide local […]
Meet Aclairo Pharmaceutical Development Group
Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together. On January 1, 2016, EPL, Inc. acquired Aclairo PDG, Inc. as […]
Experimental Pathology Laboratories, Inc. (EPL) Acquires Aclairo Pharmaceutical Development Group, Inc.
EPL and Aclairo Combine Preclinical Services Expertise EPL is pleased to announce that it has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo) which provides independent and objective nonclinical, regulatory, and clinical ADME/DMPK expert strategy and implementation to the pharmaceutical and drug device industries. “Aclairo’s team of industry and ex-FDA experts have developed a specialized consultancy […]
On-Time Pathology Reporting
It is every client’s desire and expectation that their study report will be completed “On-Time” or better yet, be available ahead of schedule. There are a number of factors that determine whether a pathology report will be early, on time, or in the worst case scenario, delayed. Most situations are readily managed, but in rare […]
EPL Clinical Pathology Evaluation and Consultation Services
Experimental Pathology Laboratories, Inc. (EPL) is pleased to announce that Dr. Valerie Barlow will be providing clinical pathology evaluation and consultation services for EPL. Dr. Valerie G. Barlow holds a DVM, a Master of Science and Ph.D., and is a Diplomate of the American College of Veterinary Pathologists (clinical pathology). Dr. Barlow was born and […]
The Benefits of Immunohistochemistry (IHC)
Immunohistochemistry (IHC) has become a routinely used methodology for investigative and diagnostic evaluations that utilizes antigen-antibody reactions to identify antigens within cells or tissues. While antigens are usually proteins, other antigenic biological products can also be recognized by antibodies including carbohydrates, lipids, nucleic acids, and others. The identification and localization of tissue antigens using IHC […]
EPL, Inc. Opens a Midwest Office in West Lafayette, Indiana
Experimental Pathology Laboratories, Inc. (EPL) opened a Midwest facility on September 1, 2014. This office is headed by Dr. Paul Snyder formerly a Professor at Purdue University. The Midwest office is located in the Purdue Research Park at 1305 Cumberland Ave., West Lafayette, IN. With this central location, Dr. Snyder will be able to provide local […]
Evolving Roles of the Toxicologic Pathologist in Multi-disciplinary Research
The role of the toxicologic pathologist is continuously evolving and becoming ever more complex, as novel tools are being developed to identify structural and biochemical changes that result from exposure to toxic substances, and elucidate mechanisms of action by which toxins may potentially impact animal and human health. Recently, EPL has been working with ToxStrategies […]